Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AI24
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003824 | catalytic activity | 1 | 2 |
GO:0004518 | nuclease activity | 4 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0016787 | hydrolase activity | 2 | 2 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.327 |
CLV_PCSK_KEX2_1 | 101 | 103 | PF00082 | 0.224 |
CLV_PCSK_KEX2_1 | 169 | 171 | PF00082 | 0.544 |
CLV_PCSK_PC1ET2_1 | 101 | 103 | PF00082 | 0.224 |
CLV_PCSK_PC1ET2_1 | 169 | 171 | PF00082 | 0.517 |
CLV_PCSK_SKI1_1 | 174 | 178 | PF00082 | 0.671 |
CLV_Separin_Metazoa | 151 | 155 | PF03568 | 0.224 |
DEG_APCC_DBOX_1 | 56 | 64 | PF00400 | 0.422 |
DOC_CYCLIN_RxL_1 | 101 | 115 | PF00134 | 0.373 |
DOC_MAPK_gen_1 | 101 | 111 | PF00069 | 0.341 |
DOC_MAPK_gen_1 | 55 | 63 | PF00069 | 0.408 |
DOC_MAPK_HePTP_8 | 48 | 60 | PF00069 | 0.586 |
DOC_MAPK_MEF2A_6 | 51 | 60 | PF00069 | 0.671 |
DOC_PP1_RVXF_1 | 105 | 112 | PF00149 | 0.224 |
DOC_PP4_FxxP_1 | 138 | 141 | PF00568 | 0.422 |
DOC_USP7_MATH_1 | 13 | 17 | PF00917 | 0.727 |
DOC_USP7_MATH_1 | 141 | 145 | PF00917 | 0.425 |
DOC_USP7_MATH_1 | 29 | 33 | PF00917 | 0.439 |
DOC_WW_Pin1_4 | 137 | 142 | PF00397 | 0.429 |
DOC_WW_Pin1_4 | 212 | 217 | PF00397 | 0.653 |
LIG_BIR_III_2 | 28 | 32 | PF00653 | 0.661 |
LIG_BRCT_BRCA1_1 | 22 | 26 | PF00533 | 0.616 |
LIG_Clathr_ClatBox_1 | 60 | 64 | PF01394 | 0.365 |
LIG_FHA_1 | 15 | 21 | PF00498 | 0.527 |
LIG_FHA_1 | 201 | 207 | PF00498 | 0.656 |
LIG_FHA_1 | 45 | 51 | PF00498 | 0.486 |
LIG_FHA_2 | 47 | 53 | PF00498 | 0.606 |
LIG_HCF-1_HBM_1 | 40 | 43 | PF13415 | 0.542 |
LIG_Integrin_RGD_1 | 98 | 100 | PF01839 | 0.224 |
LIG_LIR_Apic_2 | 137 | 141 | PF02991 | 0.422 |
LIG_LIR_Gen_1 | 103 | 113 | PF02991 | 0.304 |
LIG_LIR_Gen_1 | 122 | 131 | PF02991 | 0.176 |
LIG_LIR_Gen_1 | 91 | 100 | PF02991 | 0.370 |
LIG_LIR_Nem_3 | 103 | 108 | PF02991 | 0.202 |
LIG_LIR_Nem_3 | 122 | 126 | PF02991 | 0.176 |
LIG_LIR_Nem_3 | 91 | 96 | PF02991 | 0.344 |
LIG_SH2_CRK | 105 | 109 | PF00017 | 0.394 |
LIG_SH2_STAP1 | 74 | 78 | PF00017 | 0.381 |
LIG_SH2_STAT5 | 81 | 84 | PF00017 | 0.330 |
LIG_SH3_3 | 111 | 117 | PF00018 | 0.365 |
LIG_SUMO_SIM_par_1 | 46 | 52 | PF11976 | 0.508 |
LIG_WRC_WIRS_1 | 135 | 140 | PF05994 | 0.422 |
MOD_CDC14_SPxK_1 | 215 | 218 | PF00782 | 0.639 |
MOD_CDK_SPxK_1 | 212 | 218 | PF00069 | 0.640 |
MOD_CK1_1 | 115 | 121 | PF00069 | 0.422 |
MOD_CK2_1 | 13 | 19 | PF00069 | 0.501 |
MOD_CK2_1 | 29 | 35 | PF00069 | 0.720 |
MOD_CK2_1 | 46 | 52 | PF00069 | 0.568 |
MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.381 |
MOD_GlcNHglycan | 203 | 206 | PF01048 | 0.738 |
MOD_GSK3_1 | 137 | 144 | PF00069 | 0.402 |
MOD_GSK3_1 | 185 | 192 | PF00069 | 0.582 |
MOD_GSK3_1 | 208 | 215 | PF00069 | 0.581 |
MOD_GSK3_1 | 9 | 16 | PF00069 | 0.674 |
MOD_N-GLC_1 | 88 | 93 | PF02516 | 0.224 |
MOD_N-GLC_2 | 3 | 5 | PF02516 | 0.711 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.625 |
MOD_NEK2_1 | 193 | 198 | PF00069 | 0.542 |
MOD_NEK2_2 | 134 | 139 | PF00069 | 0.450 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.597 |
MOD_PIKK_1 | 176 | 182 | PF00454 | 0.448 |
MOD_Plk_1 | 35 | 41 | PF00069 | 0.622 |
MOD_Plk_1 | 88 | 94 | PF00069 | 0.224 |
MOD_Plk_2-3 | 35 | 41 | PF00069 | 0.510 |
MOD_Plk_2-3 | 46 | 52 | PF00069 | 0.529 |
MOD_Plk_4 | 134 | 140 | PF00069 | 0.449 |
MOD_Plk_4 | 88 | 94 | PF00069 | 0.244 |
MOD_ProDKin_1 | 137 | 143 | PF00069 | 0.429 |
MOD_ProDKin_1 | 212 | 218 | PF00069 | 0.658 |
MOD_SUMO_rev_2 | 16 | 23 | PF00179 | 0.483 |
TRG_DiLeu_BaLyEn_6 | 104 | 109 | PF01217 | 0.301 |
TRG_DiLeu_BaLyEn_6 | 56 | 61 | PF01217 | 0.354 |
TRG_ENDOCYTIC_2 | 105 | 108 | PF00928 | 0.352 |
TRG_ER_diArg_1 | 167 | 170 | PF00400 | 0.702 |
TRG_ER_diArg_1 | 55 | 58 | PF00400 | 0.614 |
TRG_NES_CRM1_1 | 28 | 40 | PF08389 | 0.517 |
TRG_Pf-PMV_PEXEL_1 | 59 | 64 | PF00026 | 0.319 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4K0 | Leptomonas seymouri | 54% | 100% |
A0A0S4IY10 | Bodo saltans | 31% | 92% |
A0A1X0NDZ2 | Trypanosomatidae | 44% | 100% |
A0A1X0NKT8 | Trypanosomatidae | 43% | 100% |
A0A3S7WPM0 | Leishmania donovani | 73% | 100% |
A4HT00 | Leishmania infantum | 73% | 100% |
E9AKY7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 73% | 100% |
Q4QIW8 | Leishmania major | 73% | 100% |
Q5HHM4 | Staphylococcus aureus (strain COL) | 29% | 98% |
Q6GB41 | Staphylococcus aureus (strain MSSA476) | 29% | 98% |
Q6GIK1 | Staphylococcus aureus (strain MRSA252) | 29% | 98% |
Q7A6P2 | Staphylococcus aureus (strain N315) | 29% | 98% |
Q8NXI6 | Staphylococcus aureus (strain MW2) | 29% | 98% |
Q99VJ0 | Staphylococcus aureus (strain Mu50 / ATCC 700699) | 29% | 98% |